Moreover, we investigated expression and prognostic role of Tim-3, galectin-9, and other immunological features alone and in combination with well-known diagnostic and prognostic biomarkers of AML and MDS patients for a better risk stratification. The gene discussed is LGALS9; the disease is acute myeloid leukemia.